500FG

The cohort consists of 534 healthy individuals, of whom 44% are male and 56% are female, all of Western-European genetic background.

Read more →

200FG

The cohort comprises 197 healthy adults working as foresters from the ‘Geldersch Landschap’, ‘Hoge Veluwe’, ‘Twickel’, and ‘Kroondomein het Loo’ in the Netherlands. These individuals were between 23 and 73 years old, and 77% were male, and 23% female.

Read more →

2000HIV

This study consists of 1895 participants living with HIV. The majority of participants were cis-male, and of white ethnical ancestry.

Read more →

BCG-PRIME

This is a randomized, controlled, multicenter trial that included 6112 immunologically vulnerable individuals aged over 60.

Read more →

300BCG

This study comprises 325 healthy individuals, 56% of whom are female, who received the BCG vaccine.

Read more →

INFLUENZA-SHINGRIX

This cohort consist of 147 young (18-35 years of age) and older (≥60) individuals who received an inactivated quadrivalent seasonal influenza vaccine (Fluarix Tetra, IIV4), an adjuvanted herpes zoster vaccine (Shingrix, RZV) or a placebo.

Read more →

300OB

The 300OB cohort comprised 302 individuals between 55 and 82 years old with a body mass index (BMI) above 27 kg/m2.

Read more →

300DM

This cohort included 243 individuals of Western European ancestry with type 1 diabetes, ranging in age from 20 to 84 years.

Read more →